Insider buying last 90 days
No open-market insider purchases were filed for SMG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every SMG insider filing, plotted on the chart in Gekko.Open SMG in Gekko
NYSE: SMG
Scotts Miracle-Gro (SMG) Stock Analysis & Forecast
Oct 12 close
$49.94+0.08 (+0.2%)
Gekko Brief
AI summaryOct 12 closeScotts Miracle-Gro names Prathima Hegde as senior vice president and chief information officer, part of the SMG 2.0 push toward technology transformation, digital expansion, and brand investment. Separately, an analyst upgrades the stock to "Buy" following a 27% decline, citing a pivot toward higher-margin branded products, disciplined growth, and leverage reduction below 3.5x, with a fair value estimate near $60.
SMG closes at $49.94, down from both its 50-day average of $56.91 and 200-day average of $62.09, with the 50-day below the 200-day. The stock has fallen 11.6% over one month, 22.1% over three months, and 13.6% over one year, with a 52-week range of $47.90 to $75.34. The GekkoIndex reads 65.7, placing the stock in the Accumulation zone, down 5 points over five days. Price sits 22% below Gekko Fair Value of $64.01.
Scotts Miracle-Gro next reports earnings on 4 November 2026, before the open, 23 days away and within a typical 20-trading-day holding window; the prior quarter beat estimates ($2.82 actual versus $2.53 expected) but still produced a 6.6% negative reaction, part of an average absolute move of 6.6% across recent reports. No insider, Congress, or unusual options activity appears in the respective windows. Seasonally, the next 20 trading days have averaged a 6.9% gain across 5 years, rising in 4 of them. Consensus among 5 covering firms stands at 3 buy and 2 hold ratings, with a target of $74.17.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Scotts Miracle-Gro price vs fair value
Close $49.94200-day averageGekko Fair Value $64.01
Scotts Miracle-Gro quick facts
- Market cap
- $2.91B
- P/E ratio
- 18
- Forward P/E
- 12.9
- EPS, TTM
- $2.80
- Revenue, TTM
- $3.48B
- Profit margin
- 2.1%
- Dividend yield
- 5.34%
- Beta
- 1.85
- Volume
- 799,164 avg 1.18M
- 1-year return
- −13.6%
- Typical daily move
- ±3.5%
- Typical 20-day move
- ±8.8%
- 50-day average
- $56.91
- 200-day average
- $62.09
- Next earnings
- Nov 4 before open
- Shares outstanding
- 58.22M
Scotts Miracle-Gro swing-trade checklist
Scotts Miracle-Gro scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $49.94 is below the 50-day ($56.91) and 200-day ($62.09) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
65.7, Accumulation
Reading 65.7 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
22.0% below
Price is 22% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 23 days
Reports on Nov 4, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+6.9% on average
From this point in the calendar, the next 20 trading days averaged +6.9% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Scotts Miracle-Gro stock chart and price history
Scotts Miracle-Gro closed at $49.94 on Oct 12, 2026, −13.6% over the past year, inside a 52-week range of $47.90 to $75.34.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −11.6%
- 3 months
- −22.1%
- 6 months
- −19.3%
- 1 year
- −13.6%
The full SMG chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SMG in Gekko
Follow Scotts Miracle-Gro through every session
Put SMG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track SMG in GekkoFree for 7 days. No credit card required.
About Scotts Miracle-Gro
Scotts Miracle-Gro makes and distributes products for lawn and garden care, along with equipment for indoor and hydroponic growing. Its catalog spans fertilizers, grass seed, spreaders, garden tools, outdoor cleaners, weed and pest controls, plant nutrients, soils, mulches, organic garden products, live goods, and household insect and rodent treatments. The company is known for brand names such as Scotts, Miracle-Gro, Ortho, Turf Builder, Roundup, and AeroGarden, among others sold under its portfolio.
The business runs through three segments: U.S. Consumer, Hawthorne, and a category labeled Other. Products reach consumers through home improvement chains, mass retailers, warehouse clubs, hardware stores, nurseries, garden centers, online shops, and food and drug stores. In the indoor and hydroponic space, the company works with specialized distributors and retailers and also sells directly to growers.
Scotts Miracle-Gro traces its founding to 1868 and is headquartered in Marysville, Ohio. Its shares are listed on the NYSE under the ticker SMG.
- Listed
- NYSE
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Website
- scottsmiraclegro.com
Scotts Miracle-Gro GekkoIndex: the smart money zone
Scotts Miracle-Gro’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.7, in the Accumulation zone, down 5 points over five sessions.
65.7Accumulation
Down 5 points over five sessions, from the Buying zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 41 | −0.3% | +0.6% | ||
| Accumulation (current zone) | 273 | +0.3% | +0.7% | ||
| Neutral | 341 | +0.1% | 0.0% | ||
| Distribution | 26 | −2.5% | −3.2% | ||
| Selling | 1 | Too few readings yet | |||
Average SMG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the SMG price, zone by zone.Track SMG in Gekko
Is Scotts Miracle-Gro stock overvalued? Gekko Fair Value
Scotts Miracle-Gro trades 22.0% below Gekko Fair Value of $64.01, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Scotts Miracle-Gro shares are worth, recalculated every trading day.
$64.01
Gekko Fair Value, Oct 10, 2026
22.0% Undervalued
At the end of Aug 2026 the price was 18.1% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open SMG in Gekko
Scotts Miracle-Gro insider and Congress trading
No open-market insider purchases were filed for Scotts Miracle-Gro, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in SMG were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for SMG, plotted on the chart in Gekko.Open SMG in Gekko
Buybacks
Scotts Miracle-Gro has been buying back its own shares.
- Latest authorization
- $500.0M, Sep 15, 2026
- Bought back, quarter ended Jun 27, 2026
- $12.10M
- As a share of market cap
- 0.42%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold SMG.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
Scotts Miracle-Gro earnings: next date and track record
Scotts Miracle-Gro reports on Nov 4, 2026, before the open (23 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 4, 2026
Expected before the open, 23 days away
- EPS estimate
- −$2.21
- Revenue estimate
- $306.1M
7 of 8reports beat the EPS estimate
±6.6%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 29, 2026 AI summary
- What they said
- Scotts Miracle-Gro reported modest top-line growth in Q3 2026 (total company net sales +1% to $1.17B; YTD +2% to $2.99B), driven by strength in the U.S. Consumer business and branded product mix. Management (new CEO Nate Baxter and CFO Mark Scheiwer) emphasized the SMG 2.0 strategic shift toward faster innovation, digital/e-commerce expansion, and increased investment in brands, AI, and data. Leadership changes and organizational restructuring were announced (no COO replacement; hiring a Chief Innovation Officer and Chief Information Officer). Management reaffirmed full-year outlook and a balanced capital allocation approach (quarterly dividend focus, measured share repurchases, continued reinvestment in advertising/R&D/CapEx). They signaled confidence in delivering margin expansion through pricing, cost-out, and mix improvement, and expect gross margin expansion in fiscal 2027. Management noted some headwinds — slightly elevated retailer inventories, commodity/transportation cost pressures (diesel, freight), and geopolitical-driven market volatility — but described active mitigation (opportunistic hedging for urea, retailer programs) and will provide detailed financial targets at an upcoming Investor Day.
- Guidance
- Reaffirmed full-year net sales guidance of low-single-digit growth; management expects gross margin expansion in fiscal 2027 driven by pricing, cost-out, innovation and mix. No new numeric EPS or revenue ranges were provided on the call; details to be discussed at the Investor Day.
- Risks flagged
- Elevated retailer inventories that could pressure Q4 sales; commodity cost inflation and higher diesel/freight costs; geopolitical volatility (e.g., Iran conflict) impacting raw material markets; potential retailer pushback on pricing (though management indicated no greater pushback than typical).
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $2.82 est $2.53 | $1.17B est $1.17B | −6.6% |
| Apr 29, 2026 | $4.53 est $4.01 | $1.46B est $1.41B | −4.1% |
| Jan 28, 2026 | −$0.77 est −$1.04 | $354.4M est $357.6M | +3.5% |
| Nov 5, 2025 | −$1.96 est −$1.98 | $387.4M est $396.2M | +3.7% |
| Jul 30, 2025 | $2.59 est $2.26 | $1.19B est $1.23B | −7.7% |
| Apr 30, 2025 | $3.98 est $3.92 | $1.42B est $1.49B | −0.3% |
| Jan 29, 2025 | −$0.89 est −$1.23 | $416.8M est $392.1M | −5.0% |
| Nov 6, 2024 | −$2.31 est −$1.96 | $414.7M est $399.6M | −21.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Scotts Miracle-Gro stock forecast and analyst price targets
Analysts’ average 12-month price target for Scotts Miracle-Gro is $74.17, +48.5% from the last close, from 5 firms rating the stock in the last 90 days.
$74.17consensus 12-month target, +48.5% from the last close
Now $49.94Avg $74.17
Low $60High $78
Each firm’s latest rating in the last 90 days: 5 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 5 | Wells Fargo | $60 | +20.1% |
| Oct 2 | William Blair | — | — |
| Sep 29 | Stifel Nicolaus | $75 | +50.2% |
| Sep 15 | William Blair | — | — |
| Aug 12 | Wells Fargo | $77 | +54.2% |
+0.7%average 20-day move after past Accumulation readings
+6.9%average move over the next 20 trading days in the last 5 years
±3.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Scotts Miracle-Gro seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Scotts Miracle-Gro averaged +6.9% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.5% | 3 of 5 |
| Next 10 trading days | +0.5% | 3 of 5 |
| Next 15 trading days | +0.6% | 2 of 5 |
| Next 20 trading days | +6.9% | 4 of 5 |
| Next 30 trading days | +10.1% | 3 of 5 |
For scale, SMG’s typical 20-trading-day move in either direction is about 8.8%.
Scotts Miracle-Gro market cap and key statistics
Scotts Miracle-Gro’s market cap is $2.91B, with a P/E ratio of 18 and revenue of $3.48B over the last twelve months.
Valuation
- Market cap
- $2.91B
- P/E ratio
- 18
- Forward P/E
- 12.9
- EPS, TTM
- $2.80
- Gekko Fair Value
- $64.01
Trading
- Volume
- 799,164
- Avg volume, 20 days
- 1.18M
- 52-week high
- $75.34
- 52-week low
- $47.90
- Shares outstanding
- 58.22M
Financials
- Revenue, TTM
- $3.48B
- Profit margin
- 2.1%
- Return on equity
- -47.6%
- Quarterly earnings growth, YoY
- −25.5%
Risk and income
- Beta
- 1.85
- Typical daily move
- ±3.5%
- Typical 20-day move
- ±8.8%
- Dividend yield
- 5.34%
Scotts Miracle-Gro stock news this week
2 headlines about Scotts Miracle-Gro from the past week, newest first, each linking to the publisher.
Scotts Miracle-Gro peers
Scotts Miracle-Gro’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| NTRNutrien | Accumulation | 1.8% below |
| CFCF Industries | Accumulation | 36.1% below |
| ICLICL | Accumulation | 8.3% below |
| MOSMosaic | Buying | 30.9% below |
| UANCVR Partners | Accumulation | 36.2% below |
| ODCOil-Dri Corporation Of America | Accumulation | 1.7% below |
A peer links to its own page where one exists.
Scotts Miracle-Gro stock FAQ
What is Scotts Miracle-Gro’s market cap?
Scotts Miracle-Gro’s market cap is $2.91B at the Oct 12, 2026 close of $49.94, with 58.22M shares outstanding. The shares trade on a P/E ratio of 18.
What is the Scotts Miracle-Gro stock forecast?
The consensus analyst 12-month price target for Scotts Miracle-Gro is $74.17, +48.5% from the last close. Of the 5 firms that rated the stock in the last 90 days, 3 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Scotts Miracle-Gro stock overvalued or undervalued?
On Gekko’s estimate Scotts Miracle-Gro is undervalued: the Oct 12, 2026 close of $49.94 is 22.0% below Gekko Fair Value of $64.01. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Scotts Miracle-Gro report earnings next?
Scotts Miracle-Gro is expected to report on Nov 4, 2026, before the market opens (23 days away). Analysts expect earnings of −$2.21 per share on revenue of $306.1M. Scotts Miracle-Gro beat the earnings estimate in 7 of its last 8 reports, moving 6.6% on average across the report.
What is Scotts Miracle-Gro’s 52-week high and low?
Scotts Miracle-Gro’s 52-week high is $75.34 and its 52-week low is $47.90; it closed at $49.94 on Oct 12, 2026, −13.6% over the past year. Over the last five years the shares peaked at $180.43 on Nov 12, 2021.
Is Scotts Miracle-Gro stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Scotts Miracle-Gro the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.